Skip to content

Clinical trials

Active, not recruiting Neurodegenerative Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Status: Active, not recruiting Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20202
20211
20234
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S2
Bial R&D Investments, S.A.1
Bristol-Myers Squibb1
EIP Pharma Inc1
Eli Lilly and Company1
Emalex Biosciences Inc.1
Michael J. Fox Foundation for Parkinson's Research1
Sage Bionetworks1
Thomas Jefferson University1
University of Arizona1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases12
Central Nervous System Diseases6
Brain Diseases5
Movement Disorders4
Nervous System Diseases4
Parkinson Disease4
Alzheimer Disease3
Mental Disorders3
Basal Ganglia Diseases2
Dementia2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.